Tomas Jelinek1, Tereza Sevcikova2, David Zihala2, Tereza Popkova2, Veronika Kapustova2,3, Lucie Broskevicova2, Lenka Capkova4, Lucie Rihova5, Renata Bezdekova5, Sabina Sevcikova6, Vladimir Zidlik7, Martin Havel8, Hana Plonkova2, Alexandra Jungova9, Jiri Minarik10, Martin Stork11, Ludek Pour11, Petr Pavlicek12, Ivan Spicka13, Vladimir Maisnar14, Jakub Radocha14, Michal Simicek2, Roman Hajek2. 1. Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. tomas.jelinek.md@gmail.com. 2. Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. 3. Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic. 4. Institute of Biostatistics and Analyses, Ltd, Brno, Czech Republic. 5. Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic. 6. Babak Myeloma Group, Department of Pathofysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. 7. Department of Pathology, University Hospital Ostrava, Ostrava, Czech Republic. 8. Department of Nuclear Medicine, University Hospital Ostrava, Ostrava, Czech Republic. 9. Hematology and Oncology Department, Charles University Hospital Pilsen, Czechia, Czech Republic. 10. Department of Hematooncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Czechia, Czech Republic. 11. Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine Masaryk University, Czechia, Czech Republic. 12. Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic. 13. 1st Medical Department-Clinical Department of Haematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic. 14. 4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
Authors: Abdullah Al Emran; Aniruddha Chatterjee; Euan J Rodger; Jessamy C Tiffen; Stuart J Gallagher; Michael R Eccles; Peter Hersey Journal: Trends Immunol Date: 2019-03-07 Impact factor: 16.687
Authors: Inger S Nijhof; Tineke Casneuf; Jeroen van Velzen; Berris van Kessel; Amy E Axel; Khaja Syed; Richard W J Groen; Mark van Duin; Pieter Sonneveld; Monique C Minnema; Sonja Zweegman; Christopher Chiu; Andries C Bloem; Tuna Mutis; Henk M Lokhorst; A Kate Sasser; Niels W C J van de Donk Journal: Blood Date: 2016-06-15 Impact factor: 22.113
Authors: Priya Choudhry; Margarette C Mariano; Huimin Geng; Thomas G Martin; Jeffrey L Wolf; Sandy W Wong; Nina Shah; Arun P Wiita Journal: Leukemia Date: 2019-10-08 Impact factor: 11.528
Authors: Meletios A Dimopoulos; Philippe Moreau; Evangelos Terpos; María-Victoria Mateos; Sonja Zweegman; Gordon Cook; Michel Delforge; Roman Hájek; Fredrik Schjesvold; Michele Cavo; Hartmut Goldschmidt; Thierry Facon; Hermann Einsele; Mario Boccadoro; Jesús San-Miguel; Pieter Sonneveld; Ulrich Mey Journal: Hemasphere Date: 2021-02-03
Authors: Nico Gagelmann; Diderik-Jan Eikema; Simona Iacobelli; Linda Koster; Hareth Nahi; Anne-Marie Stoppa; Tamás Masszi; Denis Caillot; Stig Lenhoff; Miklos Udvardy; Charles Crawley; William Arcese; Clara Mariette; Ann Hunter; Xavier Leleu; Martin Schipperus; Michel Delforge; Pietro Pioltelli; John A Snowden; Maija Itälä-Remes; Maurizio Musso; Anja van Biezen; Laurent Garderet; Nicolaus Kröger Journal: Haematologica Date: 2018-02-01 Impact factor: 9.941
Authors: Ondrej Venglar; Julio Rodriguez Bago; Benjamin Motais; Roman Hajek; Tomas Jelinek Journal: Front Immunol Date: 2022-01-11 Impact factor: 7.561
Authors: Martin Stork; Sabina Sevcikova; Jiri Minarik; Petra Krhovska; Jakub Radocha; Lenka Pospisilova; Lucie Brozova; Jiri Jarkovsky; Ivan Spicka; Jan Straub; Petr Pavlicek; Alexandra Jungova; Tomas Jelinek; Viera Sandecka; Vladimir Maisnar; Roman Hajek; Ludek Pour Journal: Br J Haematol Date: 2021-11-02 Impact factor: 8.615